Immunai emerges from stealth mode with $20m in seed funding
Huge congratulations to our resident company, Immunai, on their new funding (and incredible work). They emerged from stealth mode today...
Immunai emerges from stealth mode with $20m in seed funding
Compass Pathways raises $80m for treatment-resistant depression
PRESS RELEASE: C16 Biosciences Raises $20 Million Series A to Produce Bio-Based Palm Oil Alternative
PWC Life Sciences Forum
Black Diamond Therapeutics makes waves as they debut the largest biotech IPO in recent history
Biolabs@NYULangone Resident Companies Are Hiring!
Elabs Bootcamp Days 5 and 6 held at Biolabs@NYULangone
Bristol-Myers Squibb Awards Three Golden Tickets at Biolabs@NYULangone
Biolabs@NYULangone Official Ribbon Cutting